GST NEWS
Pharma stockists see fall in business transactions post-GST: survey
Pharma stockists see fall in business transactions post-GST: survey
Sep 13, 2017

With retailers staying cautious in building up inventories of drugs, chemists and stockists of pharmaceutical products reported a fall in transactions after the goods and services tax (GST) took effect on 1 July, according to a pan-India survey conducted by global healthcare information provider QuintilesIMS.

For this survey, QuintilesIMS interviewed 350 stockists and 149 chemists to study the impact of GST on the pharma supply chain. 90% of the stockists said their sales to chemists had declined post-GST.

Of the total, 34% stockists said the fall in sales was up to 10%, while 9% stockists said the decline was over 40%.

In transition to GST, retailers were trying to clear their stocks, which is why stockists saw an impact on their business. Overall inventory building at stockist as well as the retail level remained subdued, Prem Sethi, director, new offerings development and product management at QuintilesIMS, said.

According to the market research unit of the All India Organisation of Chemists and Druggists (AIOCD), distributors or stockists were holding 28 days of inventories as of 7 August, which is higher than 17 days as of June-end but still lower than average inventory of 40 days at the end of May.

Ahead of the debut of GST on 1 July, medicine distributors had reduced stocks to avoid potential losses. Under GST, most medicines are taxed at 12%, while life-saving drugs, including insulin, are taxed at 5%.

On the pre-GST stock, distributors can avail of 100% credit on Cenvat (central value added tax) if they possess a central excise invoice issued by the manufacturer, importer, super-stockist or carrying and forwarding (C&F) agent. In case they do not have an excise invoice, then credit can be availed of only on 40% of the central GST, which could lead to losses.

The de-stocking in the trade channel ahead of GST impacted India business growth of most pharmaceutical companies in the quarter ended June.

The Indian pharmaceutical market contracted 2.4% on year to Rs9,280 crore in July due to operational issues faced by the industry for GST implementation, as per data from the market research unit of AIOCD. The market showed modest improvement in August, registering on-year growth of 2.4% to Rs10,317 crore.

According to QuintilesIMS survey, stockists and chemists believe teething troubles on GST implementation will end in one to three months. Already 97% of stockists and 61% of chemists have upgraded their software in accordance with GST policy and the remaining are likely to do so in up to three months.

On the whole GST is expected to bring in operational efficiency in the supply chain as inter-state transactions will become tax-neutral and companies may no longer need state-wise carrying and forwarding agents but stockists and chemists have not seen such efficiencies playing out so far, as per the survey.

Source :  Livemint

Top Stories
Streamlining move: GST forms may go from 3 to 1 to ease the procedure
The Goods and Services Tax Council may consider merging triplicate comprehensive tax return forms (G...
Dec 28, 2017
465 Views
Budget 2018-19: GST Transitional Credit Scheme Likely to be Extended
The Central government might give a massive relief to companies as it may announce an extension in i...
Jan 9, 2018
691 Views
GST Council makes e-way bill mandatory for goods movement from 1 February
Federal indirect tax body the Goods and Services Tax Council on Saturday decided to make electronic ...
Dec 16, 2017
234 Views
GST Council set to ease refund procedures for exporters in Jan meet
While 2017 was a year of transition for businesses as India switched to a new indirect tax regime, 2...
Dec 29, 2017
171 Views
GST council meeting: Digital camera, bio-diesel vehicles may get cheaper
In its next meeting, GST Council—the apex decision making body of the new indirect tax system—may re...
Jan 8, 2018
138 Views
Articles on GST